Error: Could not add to watchlist. X
+ Watchlist

Omeros Corp

OMER:US
NASDAQ GM
25.71
USD
0.85
3.20%
As of 8:10 PM EDT 6/23/2017
Open
26.34
Day Range
24.99 - 26.60
Volume
2,388,267
Previous Close
26.56
52Wk Range
7.20 - 27.09
1 Yr Return
150.10%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
26.34
Day Range
24.99 - 26.60
Volume
2,388,267
Previous Close
26.56
52Wk Range
7.20 - 27.09
1 Yr Return
150.10%
YTD Return
159.17%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.37
Market Cap (b USD)
1.130
Shares Outstanding (m)
43.940
Price/Sales (TTM)
23.19
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery, and pain management.
Address
201 Elliott Avenue West
Seattle, WA 98119
United States
Phone
1-206-676-5000
  • Gregory A Demopulos "Greg"
    Chairman/Pres/CEO/Co-Founder
  • Leonard M Blum
    Chief Bus & Commercial Officer
  • Michael A Jacobsen
    VP:Finance/Chief Acctg Ofcr/Treasurer
  • J Steven Whitaker
    VP:Clinical Dev/Chief Med Ofcr
  • George A Gaitanaris
    VP:Science/Chief Scientific Ofcr
Show More